A pharmacokinetic and pharmacodynamic study of the new anthracycline pirarubicin in breast cancer patients
✍ Scribed by Jacques Robert; Alain Monnier; Nathalie Poutignat; Patrice Hérait
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 457 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To investigate the value of using changes in three parameters (tumor size, transfer constant (K^trans^), and rate constant (k~ep~)) obtained after the first treatment‐cycle in predicting the final clinical response after two to four cycles of neoadjuvant anthracycline and cy
This double-blind randomized, crossover study was undertaken to determine the pharmacokinetic properties of nifedipine retard and atenolol when given separately, as a free or a fixed combination, compared with placebo in 15 healthy male volunteers. There was no difference between the three atenolol